Allarity Therapeutics, Inc. (ALLR)
Last updated: 2026-10-23 05:36:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Allarity Therapeutics, Inc. (ALLR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.85, with a market capitalization of $14.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.77 to $1.84. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$14.00M | |
$0.89 | |
$15,288,000.00 | |
$0.61 | |
$0.88 | |
76.48K | |
105.70K | |
-- | |
$1.84 | |
$0.77 | |
-- | |
-- |
Allarity Therapeutics, Inc. (ALLR) Latest Closing Stock Price
Allarity Therapeutics, Inc. (ALLR) last closed at $0.88 as of 2026-10-22 23:08:00, unchanged from the previous close of $0.88.
During the latest regular trading session, ALLR traded between $0.61 and $15,288,000.00, with a volume of 76.48K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Allarity Therapeutics, Inc. (ALLR) 7-Day Stock Price Change
Over the past seven days, Allarity Therapeutics, Inc. (ALLR) moved from $0.87 to $0.85, representing a decline of 3.01% ($0.03).
The stock traded between $0.80 and $0.92 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 142.06 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
ALLR 52-Week Price Position
Position in Range: 7.3%
ALLR is currently trading at $0.85, placing it 7.3% of the way from its 52-week low of $0.77 to its 52-week high of $1.84. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Allarity Therapeutics, Inc. (ALLR)?
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
Allarity Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Allarity Therapeutics, Inc. (ALLR) Stock on MEXC
Eligible investors can buy real shares of Allarity Therapeutics, Inc. (ALLR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Allarity Therapeutics, Inc. (ALLR) stock price today?
2.Is ALLR stock going up or down today?
3.What is ALLR pre-market price?
4.What is ALLR after-hours price?
5.Is ALLR stock trading now?
6.Where does ALLR sit relative to its 52-week high and low?
7.What sector is Allarity Therapeutics, Inc. in?
8.What is Allarity Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is ALLR valued in terms of P/E ratio and EPS?
10.Does Allarity Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ALLR Stock Calculator
Estimate the value between ALLR shares and USD.
ALLR Shares to USD
1.00 ALLR shares = 0.847 USD
Calculations are estimates based on the latest available price and are for reference only.



